Skip to content

Sanara MedTech Inc. SMTI Finite Lived Intangible Assets Amortization Expense After Year Five

Finite Lived Intangible Assets Amortization Expense After Year Five at other companies

IAR
Integra LifeSciencesIART
Solventum logo
SolventumSOLV

Other financials

Income statement

See full
Revenue$27.8M+18.6%
Gross profit$25.9M+19.8%
Operating income$2.6M+221%
Net income$459.0K+113%
EPS (diluted)$0.05+112%

Balance sheet

See full
Cash & equivalents$13.6M-34.3%
Total debt$48.4M+8.2%
Total equity$7.0M-80.8%
Total assets$69.3M-28.1%

Cash flow

See full
Operating cash flow-$2.5M-23.3%
CapEx$43.8K-97.5%
Free cash flow-$2.5M+32.6%

Valuation

See full
Market cap$216.18M-9.7%
Enterprise value$250.95M-6.5%
P/S-0.5×

Profitability

See full
Gross margin92.9%+1.8pp
Operating margin6.1%+5.1pp
Net margin-31.2%-93.4pp
FCF margin-9.8%-3.5pp

Returns & leverage

See full
Return on equity-153.7%-199pp
Debt / equity6.9×+5.7×
Current ratio2.3×-0.5×

Where this comes from

Reported directly by Sanara MedTech Inc. in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive.

The official record: Sanara MedTech Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sanara MedTech Inc.'s finite lived intangible assets amortization expense after year five.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sanara MedTech Inc.'s finite lived intangible assets amortization expense after year five?
Sanara MedTech Inc. (SMTI) reported finite lived intangible assets amortization expense after year five of $7.07M in Q1 2026.
How has Sanara MedTech Inc.'s finite lived intangible assets amortization expense after year five changed year-over-year?
Sanara MedTech Inc.'s finite lived intangible assets amortization expense after year five decreased by 64.4% year-over-year, from $19.85M to $7.07M.
What is the long-term trend for Sanara MedTech Inc.'s finite lived intangible assets amortization expense after year five?
Over 4 years (2021 to 2025), Sanara MedTech Inc.'s finite lived intangible assets amortization expense after year five has grown at a 34.9% compound annual growth rate (CAGR), from $2.56M to $8.49M.